ii-iii-site-selection-995x60.png ii-iii-site-selection-995x60.png

FEATURED ARTICLES

  • Become The Clinical Partner Of Choice
    Become The Clinical Partner Of Choice

    Many pharmaceutical companies have started to look at their processes through the lens of valued, external partners. While companies will continue to evaluate the effectiveness of their external partners, many are increasingly looking in the mirror to see at what kind of partner they are to work with.

  • Biopharma Trends That Will Impact The Industry In 2016
    Biopharma Trends That Will Impact The Industry In 2016

    The beginning of the year is always a good time to take a look ahead at the trends most likely to impact the industry in the coming months. One area that is changing quickly, and which promises to impact clinical trials in the coming years, is biopharma. I recently spoke with Jim Esinhart, CEO of Chiltern, about some of these trends, including study protocols, big data, mergers, and new technologies.

  • What You Need To Know About FDA’s Clinical Outcome Assessment Compendium
    What You Need To Know About FDA’s Clinical Outcome Assessment Compendium

    One of the goals of CDER (The FDA’s Center for Drug Evaluation and Research) is to foster patient-focused drug development. As part of that effort, the agency has published a compendium of clinical outcome assessments (COAs) to promote the use of patient-focused outcome measurement in the drug development process.

More Featured Articles

SERVICES AND PRODUCTS

Study Start Up Study Start Up

One of the many challenges in conducting clinical trials is the speed to completion and finalization of essential and regulatory documents by the investigative site personnel.

Electronic Regulatory & Study Binders Electronic Regulatory & Study Binders

All clinical trials collect regulatory documentation in order to receive authorization to conduct the trial at investigative sites. Trials require a Regulatory Binder and many keep separate Study Binders.

Clinical Trial Feasibility Clinical Trial Feasibility

Delays in research have significant time and cost implications and negatively impact an organization, regardless of size or financial stability. The potential for delays can be decreased or mitigated through comprehensive planning.

CRISTal - Clinical Research Interactive Selection Tool       CRISTal - Clinical Research Interactive Selection Tool

CRISTal is RDP Clinical Outsourcing’s proprietary software platform that facilitates the strategic identification of sites, as well as our highly experienced regional monitors.

Imaging Core Lab Services Imaging Core Lab Services

ICON Medical Imaging’s use of superior technology, advanced science and experienced people lead to the ultimate goal: results.

Product Lifecycle Consultancy Services Product Lifecycle Consultancy Services

ICON’s Lifecycle Sciences group offers the full range of services to assist clients with activities throughout the product lifecycle.

More Services & Products